Prion Protein Does Not Interfere with SNARE Complex Formation and Membrane Fusion

다국어 초록 (Multilingual Abstract)

In prion disease, spongiform neurodegeneration is preceded by earlier synaptic dysfunction. There is evidence that soluble N-ethylmaleimide sensitive factor attachment receptor (SNARE) complex formation is reduced in scrapie-infected in vivo models, which might explain this synaptic dysfunction because SNARE complex plays a crucial role in neuroexocytosis. In the present study, however, it is shown that prion protein (PrP) does not interfere with SNARE complex formation of 3 SNARE proteins: syntaxin 1a, SNAP-25, and synaptobrevin. Sodium dodecyl sulfate-resistant complex formation, SNAREdriven membrane fusion, and neuroexocytosis of PC12 cells were not altered by PrP. Thus, PrP does not alter synaptic function by directly interfering with SNARE complex formation.

목차 (Table of Contents)

• Abstract
• Introduction
• Materials and Methods
• Results and Discussion
• Acknowledgments
• References

참고문헌 (Reference)

1 Asuni AA, "Unaltered SNARE complex formation in an in vivo model of prion disease" 1233 : 1-7, 2008

2 Requena JR, "Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form" 30 : 141-147, 2001

3 Poirier MA, "The synaptic SNARE complex is a parallel four-stranded helical bundle" 5 : 765-769, 1998

4 Kitamoto T, "The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system" 141 : 271-277, 1992

5 Hay DW, "The effects of calcium channel inhibitors and other procedures affecting calcium translocation on drug-induced rhythmic contractions in the rat vas deferens" 79 : 347-362, 1983

6 Legname G, "Synthetic mammalian prions" 305 : 673-676, 2004

7 Clinton J, "Synaptic degeneration is the primary neuropathological feature in prion disease: A preliminary study" 4 : 65-68, 1993

8 Cunningham C, "Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease" 17 : 2147-2155, 2003

9 Jeffrey M, "Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus" 26 : 41-54, 2000

10 Brunger AT, "Structure of proteins involved in synaptic vesicle fusion in neurons" 30 : 157-171, 2001

11 Sorensen JB, "Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles" 25 : 955-966, 2006

12 Jahn R, "SNAREs-engines for membrane fusion" 7 : 631-643, 2006

13 Chen YA, "SNARE-mediated membrane fusion" 2 : 98-106, 2001

14 Weber T, "SNARE pins: Minimal machinery for membrane fusion" 92 : 759-772, 1998

15 Melia TJ Jr, "Putting the clamps on membrane fusion: How complexin sets the stage for calcium-mediated exocytosis" 581 : 2131-2139, 2007

16 Prusiner SB, "Prions" 95 : 13363-13383, 1998

17 Russelakis-Carneiro M, "Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts" 165 : 1839-1848, 2004

18 Ferrer I, "Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease" 97 : 715-726, 2000

19 Kocisko DA, "New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products" 77 : 10288-10294, 2003

20 Pobbati AV, "N- to C-terminal SNARE complex assembly promotes rapid membrane fusion" 313 : 673-676, 2006

21 Aguzzi A, "Mammalian prion biology: One century of evolving concepts" 116 : 313-327, 2004

22 Porat Y, "Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism" 67 : 27-37, 2006

23 Richardson CM, "Inhibition of acetylcholine release from presynaptic terminals of skate electric organ by calcium channel antagonists: a detailed pharmacological study" 35 : 1537-1546, 1996

24 Jung CH, "Inhibition of SNARE-driven neuroexocytosis by plant extracts" 2008

25 Castilla J, "In vitro generation of infectious scrapie prions" 121 : 195-206, 2005

26 Mehlhorn I, "High-level expression and characterization of a purified 142-residue polypeptide of the prion protein" 35 : 5528-5537, 1996

27 Xu Y, "Hemifusion in SNARE-mediated membrane fusion" 12 : 417-422, 2005

28 Ferrer I, "Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease" 6 : 92-100, 1999

29 Jeffrey M, "Early unsuspected neuron and axon terminal loss in scrapie­infected mice revealed by morphometry and immunocytochemistry" 21 : 41-49, 1995

30 Hayashi T, "Disassembly of the reconstituted synaptic vesicle membrane fusion complex in vitro" 14 : 2317-2325, 1995

31 Shin JI, "Deep membrane insertion of prion protein upon reduction of disulfide bond" 377 : 995-1000, 2008

32 Sutton RB, "Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution" 395 : 347-353, 1998

33 Ma J, "Conversion of PrP to a self-perpetuating PrPSc­like conformation in the cytosol" 298 : 17-85, 2002

34 Chen Y, "Constitutive versus regulated SNARE assembly: A structural basis" 23 : 681-689, 2004

35 Kocisko DA, "Cell-free formation of protease-resistant prion protein" 370 : 471-474, 1994

36 Ishida H, "Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factor-treated PC12 cells" 310 : 881-889, 2004

37 Ray P, "Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells" 268 : 11057-11064, 1993

38 Sandberg MK, "Altered interaction and expression of proteins involved in neurosecretion in scrapie-infected GT1-1 cells" 280 : 1264-1271, 2005

39 Siso S, "Abnormal synaptic protein expression and cell death in murine scrapie" 103 : 615-626, 2002

40 Jung CH, "A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion" 275 : 3051-3063, 2008